December 2014 | The Journal of Targeted Therapies in Cancer

BioT3 Integrates Diagnosis With Actionable Biomarkers in Metastatic Cancer

January 28, 2015

Clinical Articles

Metastatic disease accounts for the vast majority of cancer-related deaths. Ensuring a definitive diagnosis and the most effective treatment in a timely fashion is essential for extending life expectancy.